Quest Diagnostics Inc (DGX)
154.80
+0.38
(+0.25%)
USD |
NYSE |
Sep 27, 16:00
154.71
-0.09
(-0.06%)
Pre-Market: 20:00
Quest Diagnostics SG&A Expense (Annual): 1.642B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.642B |
| December 31, 2022 | 1.874B |
| December 31, 2021 | 1.727B |
| December 31, 2020 | 1.55B |
| December 31, 2019 | 1.457B |
| December 31, 2018 | 1.424B |
| December 31, 2017 | 1.443B |
| December 31, 2016 | 1.38B |
| December 31, 2015 | 1.679B |
| December 31, 2014 | 1.728B |
| December 31, 2013 | 1.704B |
| December 31, 2012 | 1.745B |
| December 31, 2011 | 1.743B |
| December 31, 2010 | 1.659B |
| Date | Value |
|---|---|
| December 31, 2009 | 1.748B |
| December 31, 2008 | 1.737B |
| December 31, 2007 | 1.613B |
| December 31, 2006 | 1.434B |
| December 31, 2005 | 1.224B |
| December 31, 2004 | 1.210B |
| December 31, 2003 | 1.166B |
| December 31, 2002 | 1.075B |
| December 31, 2001 | 1.019B |
| December 31, 2000 | 1.001B |
| December 31, 1999 | 643.40M |
| December 31, 1998 | 481.60M |
| December 31, 1997 | 502.10M |
| December 31, 1996 | 495.32M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
1.457B
Minimum
2019
1.874B
Maximum
2022
1.65B
Average
1.642B
Median
2023
SG&A Expense (Annual) Benchmarks
| DaVita Inc | 1.474B |
| Universal Health Services Inc | 7.249B |
| Labcorp Holdings Inc | 2.021B |
| Exact Sciences Corp | 1.620B |
| Neuronetics Inc | 72.74M |